Major response to imatinib mesylate in KIT-mutated melanoma

F. Stephen Hodi, Philip Friedlander, Christopher L. Corless, Michael C. Heinrich, Suzanne Mac Rae, Andrea Kruse, Jyothi Jagannathan, Annick D. Van Den Abbeele, Elsa F. Velazquez, George D. Demetri, David E. Fisher

Research output: Contribution to journalArticle

342 Scopus citations
Original languageEnglish (US)
Pages (from-to)2046-2051
Number of pages6
JournalJournal of Clinical Oncology
Volume26
Issue number12
DOIs
StatePublished - Sep 15 2008

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Hodi, F. S., Friedlander, P., Corless, C. L., Heinrich, M. C., Mac Rae, S., Kruse, A., Jagannathan, J., Van Den Abbeele, A. D., Velazquez, E. F., Demetri, G. D., & Fisher, D. E. (2008). Major response to imatinib mesylate in KIT-mutated melanoma. Journal of Clinical Oncology, 26(12), 2046-2051. https://doi.org/10.1200/JCO.2007.14.0707